Medical Condition News

RSS
New atlas can help understand the relationship between healthy and breast cancer cells

New atlas can help understand the relationship between healthy and breast cancer cells

Investigational drug reduced triglycerides in patients with severe hypertriglyceridemia, acute pancreatitis

Investigational drug reduced triglycerides in patients with severe hypertriglyceridemia, acute pancreatitis

Frequent blood testing protocol for heart attack did not improve patient outcomes after one year

Frequent blood testing protocol for heart attack did not improve patient outcomes after one year

The Lancet outlines 10 ambitious recommendations to improve health outcomes for women

The Lancet outlines 10 ambitious recommendations to improve health outcomes for women

Brief pulses of ultrasound delivered to nerves in renal arteries reduce drug-resistant blood pressure

Brief pulses of ultrasound delivered to nerves in renal arteries reduce drug-resistant blood pressure

Retinal scans may provide an early sign of Alzheimer's disease

Retinal scans may provide an early sign of Alzheimer's disease

Older heart failure patients significantly benefit from tailored cardiac rehab program

Older heart failure patients significantly benefit from tailored cardiac rehab program

Researchers compare characteristics and outcomes of hip fracture patients during pre- and post-COVID-19 outbreak

Researchers compare characteristics and outcomes of hip fracture patients during pre- and post-COVID-19 outbreak

Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack

Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack

Groundbreaking study optimizes patient's own immune system to fight tumors

Groundbreaking study optimizes patient's own immune system to fight tumors

Minorities substantially underrepresented in pancreatic cancer clinical trials

Minorities substantially underrepresented in pancreatic cancer clinical trials

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

A look at how coronavirus disease (COVID-19) affects Parkinson's

A look at how coronavirus disease (COVID-19) affects Parkinson's

Novel nanotechnology could change the lives of people living with cystic fibrosis

Novel nanotechnology could change the lives of people living with cystic fibrosis

NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells

NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells

Insured cancer patients treated at Kaiser Permanente have better survival rates

Insured cancer patients treated at Kaiser Permanente have better survival rates

New app focuses on supporting patients with life-limiting illnesses in Ethiopia

New app focuses on supporting patients with life-limiting illnesses in Ethiopia

Obesity-related cancer deaths are declining at a slower pace, shows study

Obesity-related cancer deaths are declining at a slower pace, shows study

Black fungus complicates India's COVID pandemic

Black fungus complicates India's COVID pandemic

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.